Megafine Speciality Chemicals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 3.00 Cr
as on 17-07-2024
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.40 Cr
as on 17-07-2024
- Revenue -10.42%
(FY 2023)
- Profit 164.51%
(FY 2023)
- Ebitda 297.51%
(FY 2023)
- Net Worth 9.19%
(FY 2023)
- Total Assets 3.54%
(FY 2023)
About Megafine Speciality Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹19.40 Cr.
Ami Parikh, Rajan Parikh, and Priyakant Parikh serve as directors at the Company.
- CIN/LLPIN
U24100GJ2011PTC067724
- Company No.
067724
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmadabad City, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Megafine Speciality Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ami Parikh  | Director | 22-Jul-2013 | Current |
| Rajan Parikh | Director | 03-Nov-2011 | Current |
| Priyakant Parikh | Director | 03-Nov-2011 | Current |
Financial Performance and Corporate Structure Insights of Megafine Speciality Chemicals.
Megafine Speciality Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.42% decrease. The company also saw a substantial improvement in profitability, with a 164.51% increase in profit. The company's net worth moved up by a moderate rise of 9.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Megafine Speciality Chemicals?
In 2023, Megafine Speciality Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 16 Feb 2017 | ₹9.70 Cr | Open |
Axis Bank Limited Creation Date: 14 Feb 2017 | ₹9.70 Cr | Open |
How Many Employees Work at Megafine Speciality Chemicals?
Megafine Speciality Chemicals has a workforce of 8 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Megafine Speciality Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Megafine Speciality Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
